Botox Drug Use Investigation (Spasmodic Dysphonia)
Phase of Trial: Phase IV
Latest Information Update: 22 Jul 2019
Price : $35 *
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Dysphonia
- Focus Adverse reactions; Therapeutic Use
- Sponsors GlaxoSmithKline
- 18 Jul 2019 Status changed from active, no longer recruiting to recruiting.
- 07 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2018 Status changed from not yet recruiting to recruiting.